Our study and the findings of others suggest that the impaired cytokine secretion associated with DM observed in preclinical studies does not affect the IL-6-CRP axis during a state of high-grade inflammation of a longer duration, like CAP. This evidence concerns the gene IL6 and diabetes mellitus.